Abstract
The elaboration of a sensitive bioassay for assessment of tumour necrosis factor alpha (TNF-α) in a defined medium is described. The assay is based on the cytotoxic effect of TNF-α on a target cell line, the murine fibrosarcoma WEHI 164 clone 13. Cytotoxicity was assessed by detecting the rate of tetrazolium salt reduction employing a spectrophotometer (ELISA-reader). A similar bioassay was used previously to assess TNF-α, though this was dependent on cell growth in a medium containing serum. By employing a synthetic serum replacement, the WEHI cells were adapted to growth in a defined medium which allowed both the propagation of the cell line and the assay to be performed under completely defined conditions. Thus, factors in serum that may influence the TNF-α assessment, such as growth factors, cytokines, soluble cytokine-receptors and macroglobulin, were avoided. The only protein required in this bioassay was insulin, while albumin was added as a carrier protein and to protect the cytokine against loss of biological activity during multiple freeze and thaw cycles. The present assay was optimised to achieve a high sensitivity and, by testing endogenous TNF-α originating from the macrophage-like cell line RAW in both the serum-free and serum-based assay, we found the highest sensitivity in the assay based on defined medium. The LC50 of recombinant mouse and human TNF-α were in the serum-free and serum-based assays considered to be 25 and 50 pg mL-1, respectively. The demonstration of a culture condition that enables long-term cultivation of target cells and a bioassay in a completely defined medium is in our opinion a substantial contribution to more reliable cytokine assessment.
Similar content being viewed by others
References
Aderka D, Engelmann H, Shemer Avni Y, Hornik V, Galil A, Sarov B and Wallach D (1992) Variation in serum levels of the soluble TNF receptors among healthy individuals. Lymphokine Cytokine Res 11: 157-159.
Aggarwal BB, Eessalu TE and Hass PE (1985) Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon. Nature 318: 665-667.
Berridge MV, Tan AS, McCoy KD and Wang R (1996) The biochemical and cellular basis of cell proliferation assays that use tetrazolium salts. Biochem 4: 15-20.
Berridge MV and Tan AS (1993) Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys 303: 474-482.
Bertheussen K, Holst N, Forsdahl F and Hoie KE (1989) A new cell culture assay for quality control in IVF. Hum Reprod 4: 531-535.
Bertheussen K (1993) Growth of cells in a new defined protein-free medium. Cytotechnology 11: 219-231.
Beyaert R, Vanhaesebroeck B, Suffys P, Van Roy F and Fiers W (1989) Lithium chloride potentiates tumor necrosis factor-mediated cytotoxicity in vitro and in vivo. Proc Natl Acad Sci USA 86: 9494-9498.
Beyaert R, Heyninck K, De Valck D, Boeykens F, Van Roy F and Fiers W (1993) Enhancement of tumor necrosis factor cytotoxicity by lithium chloride is associated with increased inositol phosphate accumulation. J Immunol 151: 291-300.
Denizot F and Lang R (1986) Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89: 271-277.
Elborn JS, Delamare F, Bell SC and Shale DJ (1995) Can tumor necrosis factor-alpha (TNF-α) be reliably measured in blood? Pediatr Pulmonol 19: 226-230.
Eskandari MK, Nguyen DT, Kunkel SL and Remick DG (1990) WEHI 164 subclone 13 assay for TNF: sensitivity, specificity, and reliability. Immunol Invest 19: 69-79.
Espevik T and Nissen Meyer J (1986) A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 95: 99-105.
Feldman D and Krishnan A (1995) Estrogens in unexpected places: possible implications for researchers and consumers. Environ Health Perspect 103Suppl 7: 129-133.
Figenschau Y, Sundsfjord JA, Yousef MI, Fuskevåg OM, Sveinbjörnsson B and Bertheussen K (1997a) A simplified serum-free method for preparation and cultivation of human granulosa-luteal cells. Hum Reprod 12: 523-531.
Figenschau Y, Yousef MI, Sveinbjörnsson B and Bertheussen K (1997b) A sensitive serum-free colorimetric assay for the detection of cytotoxic effects of pesticides. J Environ Sci Health B 32: 177-194.
Fomsgaard A, Worsaae H and Bendtzen K (1988) Detection of tumour necrosis factor from lipopolysaccharide-stimulated human mononuclear cells by enzyme-linked immunosorbent assay and cytotoxicity bioassay. Scand J Immunol 27: 143-147.
Fomsgaard A, Svenson M and Bendtzen K (1989) Auto-antibodies to tumour necrosis factor alpha in healthy humans and patients with inflammatory diseases and gram-negative bacterial infections. Scand J Immunol 30: 219-223.
Fransen L, Ruysschaert MR, Van der Heyden J and Fiers W (1986) Recombinant tumor necrosis factor: species specificity for a variety of human and murine transformed cell lines. Cell Immunol 100: 260-267.
Garbin F, Eckert K and Maurer HR (1994) Evaluation of the MTT and SRB assays for testing LAK cell-mediated growth inhibition of various adherent and non-adherent tumor target cells [letter]. J Immunol Methods 170: 269-271.
Hansen MB, Nielsen SE and Berg K (1989) Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119: 203-210.
Holtmann H and Wallach D (1987) Down regulation of the receptors for tumor necrosis factor by interleukin 1 and 4 beta-phorbol-12-myristate-13-acetate. J Immunol 139: 1161-1167.
James K (1990) Interactions between cytokines and alpha 2-macroglobulin [see comments]. Immunol Today 11: 163-166.
Kramer SM and Carver ME (1986) Serum-free in vitro bioassay for the detection of tumor necrosis factor. J Immunol Methods 93: 201-206.
Lewis M, Tartaglia LA, Lee A, Bennett GL, Rice GC, Wong GH, Chen EY and Goeddel DV (1991) Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sci USA 88: 2830-2834.
Löw H, Alm B and Vallin I (1964) The use of phenazine methosulfate in the study of oxidative phosphorylation. Biochem Biophys Res Commun 14: 437-440.
Meager A, Leung H and Woolley J (1989) Assays for tumour necrosis factor and related cytokines. J Immunol Methods 116: 1-17.
Olsson I, Gatanaga T, Gullberg U, Lantz M and Granger GA (1993) Tumour necrosis factor (TNF) binding proteins (soluble TNF receptor forms) with possible roles in inflammation and malignancy. Eur Cytokine Netw 4: 169-180.
Ostrove JM and Gifford GE (1979) Stimulation of RNA synthesis in L-929 cells by rabbit tumor necrosis factor. Proc Soc Exp Biol Med 160: 354-358.
Sandberg HE (1977) Proceedings of the International Workshop on Technology for Protein Separation and Improvement of Blood Plasma Fractions. U.S. Dept. Health, Education, Welfare, U.S.A., Publ. no. (NIH) 78–1422.
Slater TF, Sawyer B and Sträuli U (1963) Studies on succinate-tetrazolium reductase systems III. Points of coupling of four different tetrazolium salts. Biochim Biophys Acta 77: 383-387.
Smith CA, Davis T, Wignall JM, Din WS, Farrah T, Upton C, McFadden G and Goodwin RG (1991) T2 open reading frame from the Shope fibroma virus encodes a soluble form of the TNF receptor. Biochem Biophys Res Commun 176: 335-342.
Sugarman BJ, Lewis GD, Eessalu TE, Aggarwal BB and Shepard HM (1987) Effects of growth factors on the antiproliferative activity of tumor necrosis factors. Cancer Res 47: 780-786.
Tada H, Shiho O, Kuroshima K, Koyama M and Tsukamoto K (1986) An improved colorimetric assay for interleukin 2. J Immunol Methods 93: 157-165.
Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL and Lowry SF (1992) Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci USA 89: 4845-4849.
Vistica DT, Skehan P, Scudiero D, Monks A, Pittman A and Boyd MR (1991) Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production [published erratum appears in Cancer Res 1991 Aug. 15;51(16):4501]. Cancer Res 51: 2515-2520.
Waage A, Brandtzaeg P, Halstensen A, Kierulf P and Espevik T (1989) The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 169: 333-338.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Figenschau, Y., Sveinbjörnsson, B. & Bertheussen, K. Improvement of a cytokine (TNF-α) bioassay by serum-free target cell (WEHI 164) cultivation. Cytotechnology 29, 121–134 (1999). https://doi.org/10.1023/A:1008052307547
Issue Date:
DOI: https://doi.org/10.1023/A:1008052307547